↓ Skip to main content

Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations

Overview of attention for article published in SpringerPlus, September 2015
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
4 Mendeley